2,3-dibenzylbutane-1,4-diol has been researched along with ryanodine in 1 studies
| Studies (2,3-dibenzylbutane-1,4-diol) | Trials (2,3-dibenzylbutane-1,4-diol) | Recent Studies (post-2010) (2,3-dibenzylbutane-1,4-diol) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 2,894 | 3 | 237 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Inoue, M; Morikawa, M; Tsuboi, M | 1 |
1 other study(ies) available for 2,3-dibenzylbutane-1,4-diol and ryanodine
| Article | Year |
|---|---|
Inhibitory effect of 2,3-dibenzylbutane-1,4-diol; a mammalian lignan, on the CA2+ channel in rabbit femoral artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzyl Compounds; Calcium Channel Blockers; Calcium Channels; Femoral Artery; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium; Rabbits; Ryanodine | 1990 |